Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors.

2574Background: Clinical and preclinical experiments suggest that the gut microbiome can affect outcome in cancer patients treated with immune checkpoint inhibitors (ICI). Most data to date has bee...